Literature DB >> 23006899

Modeling specific phobias and posttraumatic stress disorder in rodents: the challenge to convey both cognitive and emotional features.

Andrea Berardi1, Viviana Trezza, Campolongo Campolongo.   

Abstract

Aberrant emotional memory processing is a core, disabling feature of both specific phobias and posttraumatic stress disorder (PTSD), two psychiatric diseases of significant prevalence and morbidity whose cognitive symptoms cannot be adequately treated by current psychopharmacological tools. Elucidating the neurobiological mechanisms involved in the etiology of these diseases is of great interest for the identification of new therapeutics that improve not only the symptomatology but also the full recovery from the pathology. To this aim, several animal models have been proposed based on substantial resemblance between the behavioral alterations seen in animals and the human pathology. The purpose of this review is to describe and comment on the most commonly used rodent models of specific phobias and PTSD. A particular focus will be reserved to the cued version of fear conditioning, as the highly specific stimulus-bound conditioned fear response seems to fit well with clinical descriptions of phobic fear.Moreover, animal models of PTSD will be evaluated by referring to three elements that are considered essential ina valid model of this disease: stressor exposure, memory for the stressor, and anxiety-related behaviors. Finally, current therapeutic directions, with a focus on cannabinoid and glucocorticoid compounds, will be briefly outlined.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23006899     DOI: 10.1515/revneuro-2012-0054

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  8 in total

1.  N-Acetylcysteine treatment during acute stress prevents stress-induced augmentation of addictive drug use and relapse.

Authors:  Constanza Garcia-Keller; Cora Smiley; Cara Monforton; Samantha Melton; Peter W Kalivas; Justin Gass
Journal:  Addict Biol       Date:  2019-07-07       Impact factor: 4.280

2.  Long-term impact of acute restraint stress on heroin self-administration, reinstatement, and stress reactivity.

Authors:  Jordan S Carter; Angela M Kearns; Kelsey M Vollmer; Constanza Garcia-Keller; Rachel A Weber; Nathaniel L Baker; Peter W Kalivas; Carmela M Reichel
Journal:  Psychopharmacology (Berl)       Date:  2020-03-03       Impact factor: 4.530

Review 3.  The predator odor avoidance model of post-traumatic stress disorder in rats.

Authors:  Lucas Albrechet-Souza; Nicholas W Gilpin
Journal:  Behav Pharmacol       Date:  2019-04       Impact factor: 2.293

4.  The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD).

Authors:  Viviana Trezza; Patrizia Campolongo
Journal:  Front Behav Neurosci       Date:  2013-08-09       Impact factor: 3.558

5.  Enhancing Endocannabinoid Signaling via β-Catenin in the Nucleus Accumbens Attenuates PTSD- and Depression-like Behavior of Male Rats.

Authors:  Tomer Mizrachi Zer-Aviv; Larglinda Islami; Peter J Hamilton; Eric M Parise; Eric J Nestler; Brenda Sbarski; Irit Akirav
Journal:  Biomedicines       Date:  2022-07-25

6.  Defensive aggregation (huddling) in Rattus norvegicus toward predator odor: individual differences, social buffering effects and neural correlates.

Authors:  Michael T Bowen; Richard C Kevin; Matthew May; Lauren G Staples; Glenn E Hunt; Iain S McGregor
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

7.  An updated animal model capturing both the cognitive and emotional features of post-traumatic stress disorder (PTSD).

Authors:  Andrea Berardi; Viviana Trezza; Maura Palmery; Luigia Trabace; Vincenzo Cuomo; Patrizia Campolongo
Journal:  Front Behav Neurosci       Date:  2014-04-29       Impact factor: 3.558

Review 8.  Single-Prolonged Stress: A Review of Two Decades of Progress in a Rodent Model of Post-traumatic Stress Disorder.

Authors:  Michael J Lisieski; Andrew L Eagle; Alana C Conti; Israel Liberzon; Shane A Perrine
Journal:  Front Psychiatry       Date:  2018-05-15       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.